|
Gateway® pDEST™14 Vector
To fit all of your expression needs, Invitrogen offers state-of-the-art Gateway® destination vectors for expression in E. coli, insect, yeast, or mammalian cells, as well as for production of native protein or N- or C-terminal fusion proteins. All Gateway® destination vectors have attR sites for recombination with any attL-flanked fragment, regardless of whether it is an entry clone or an Ultimate™ RF Clone. The following table lists the wide range of destination vectors available.
Additional materials required, available separately: Gateway® entry clone, Gateway® LR Clonase® enzyme mix, and reaction buffer.
Vector Type: pDEST,
Gateway T7 Vectors
Cloning Method: Gateway®
Promoter: T7
Protein Tag or Fusion: Untagged
Antibiotic Resistance (Bacterial): Ampicillin (AmpR)
Product Size: 6 µg
Inducing Agent: IPTG
Selection Agent (Eukaryotic): None
Constitutive or Inducible System: Inducible
Regulatory Statement: For Research Use Only. Not for use in diagnostic procedures.
All destination vectors are provided lyophilized and supercoiled. |